Inventor · disambiguated record
Benedikt Sas
Also filed as: SAS BENEDIKT · SAS BENEDIKT J
18 granted patents·2 pending applications·139 citations·filing 1994–2019
92Inventor score
Files withKEMIN IND INC4KEMIN PHARMA B V B A4KEMIN PHARMA EUROP B V B A2PHARMA MAR S A PHARMAR2KEMIN FOODS LC1
Top patents by PatentIndex Score
20 records- 0186US5876782AMethod for the conversion of xanthophylls in plant materialKEMIN IND INC·Filed 1997·Granted Mar 2, 1999·70 cites·27 claims
- 0279US6221417B1Conversion of xanthophylls in plant material for use as a food colorantKEMIN IND INC·Filed 1998·Granted Apr 24, 2001·22 cites·4 claims
- 0374US6068997AMethod for the conversion of lecithin into lysolecithinKEMIN IND INC·Filed 1999·Granted May 30, 2000·19 cites·20 claims
- 0473US7211281B2Method for improving the activity of enzymesKEMIN IND INC·Filed 2001·Granted May 1, 2007·11 cites·9 claims
- 0568US7138531B2Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activityKEMIN PHARMA B V B A·Filed 2001·Granted Nov 21, 2006·4 cites·2 claims
- 0661US8697052B2Method for alleviating intestinal problems and novel bacterial strains thereforVAN IMMERSEEL FILIP·Filed 2010·Granted Apr 15, 2014·2 cites·7 claims
- 0759US7842719B2Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virusKEMIN FOODS LC·Filed 2003·Granted Nov 30, 2010·1 cites·3 claims
- 0851US7534871B2Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activityKEMIN PHARMA B V B A·Filed 2004·Granted May 19, 2009·0 cites·4 claims
- 0950US6297396B1Method of crystallizing and purifying alkyl gallatesFiled 1999·Granted Oct 2, 2001·5 cites·13 claims
- 1048US5571927AAreno [E]indols, preparation method and application as intermediates in the synthesis of products with antitumoral activityPHARMA MAR S A PHARMAR·Filed 1994·Granted Nov 5, 1996·5 cites·16 claims
- 1141US11608326B2Synthetic receptors for ionophoric compoundsUNIV GENT·Filed 2019·Granted Mar 21, 2023·0 cites·16 claims
- 1241US7125854B2Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasitesKEMIN PHARMA B V B A·Filed 2004·Granted Oct 24, 2006·0 cites·6 claims
- 1341US2008057047A1Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseasesSAS BENEDIKT·Filed 2006·Application pending·0 cites
- 1441US2011206636A1Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever VirusKEMIN FOODS LLC·Filed 2010·Application pending·0 cites
- 1540US7125853B2Bicyclic carbohydrate compounds useful in the treatment of infections caused by Flaviviridae sp., such as hepatitis C and bovine viral diarrhea virusesKEMIN PHARMA B V B A·Filed 2003·Granted Oct 24, 2006·0 cites·5 claims
- 1640US7098243B2Bicyclic carbohydrates as antiviral bioactives for the treatment of infections caused by the alphaherpesvirinae HSV-1 and HSV-2KEMIN PHARMA EUROP B V B A·Filed 2003·Granted Aug 29, 2006·0 cites·7 claims
- 1739US11028454B2Incorporation of thermo-resistant and/or pressure-resistant organisms in materialsMERTENS JOHAN·Filed 2009·Granted Jun 8, 2021·0 cites·21 claims
- 1837US7101908B2Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridaeKEMIN PHARMA EUROP B V B A·Filed 2003·Granted Sep 5, 2006·0 cites·8 claims
- 1935US7368475B2Furanose-type bicyclic carbohydrates with biological activityKEMIN PHARMA BVBA·Filed 2004·Granted May 6, 2008·0 cites·6 claims
- 2023US5631384AAreno [e]indols, preparation method and application as intermediates in the synthesis of products with antitumoral activityPHARMA MAR S A PHARMAR·Filed 1996·Granted May 20, 1997·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Benedikt Sas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →